Abstract
Study design
A Systematic Review
Objectives
To determine the therapeutic efficacy of in vivo reprogramming of astrocytes into neuronal-like cells in animal models of spinal cord injury (SCI).
Methods
PRISMA 2020 guidelines were utilized, and search engines Medline, Web of Science, Scopus, and Embase until June 2023 were used. Studies that examined the effects of converting astrocytes into neuron-like cells with any vector in all animal models were included, while conversion from other cells except for spinal astrocytes, chemical mechanisms to provide SCI models, brain injury population, and conversion without in-vivo experience were excluded. The risk of bias was calculated independently.
Results
5302 manuscripts were initially identified and after eligibility assessment, 43 studies were included for full-text analysis. After final analysis, 13 manuscripts were included. All were graded as high-quality assessments. The transduction factors Sox2, Oct4, Klf4, fibroblast growth factor 4 (Fgf4) antibody, neurogenic differentiation 1 (Neurod1), zinc finger protein 521 (Zfp521), ginsenoside Rg1, and small molecules (LDN193189, CHIR99021, and DAPT) could effectively reprogramme astrocytes into neuron-like cells. The process was enhanced by p21-p53, or Notch signaling knockout, valproic acid, or chondroitin sulfate proteoglycan inhibitors. The type of mature neurons was both excitatory and inhibitory.
Conclusion
Astrocyte reprogramming to neuronal-like cells in an animal model after SCI appears promising. The molecular and functional improvements after astrocyte reprogramming were demonstrated in vivo, and further investigation is required in this field.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
Data availability
All datasets for this study are available from the corresponding author upon reasonable request.
References
Sofroniew MV, Vinters HV. Astrocytes: biology and pathology. Acta Neuropathol. 2010;119:7–35. https://doi.org/10.1007/s00401-009-0619-8.
Yang T, Xing L, Yu W, Cai Y, Cui S, Chen G. Astrocytic reprogramming combined with rehabilitation strategy improves recovery from spinal cord injury. FASEB J. 2020;34:15504–15. https://doi.org/10.1096/fj.202001657RR.
Huang X, Wang C, Zhou X, Wang J, Xia K, Yang B, et al. Overexpression of the transcription factors OCT4 and KLF4 improves motor function after spinal cord injury. CNS Neurosci Ther. 2020;26:940–51. https://doi.org/10.1111/cns.13390.
Spinal cord injury n.d. https://www.who.int/news-room/fact-sheets/detail/spinal-cord-injury. Accessed 14 Jul 2023.
Thuret S, Moon LD, Gage FH. Therapeutic interventions after spinal cord injury. Nat Rev Neurosci. 2006;7:628–43. https://doi.org/10.1038/nrn1955.
Su Z, Niu W, Liu ML, Zou Y, Zhang CL. In vivo conversion of astrocytes to neurons in the injured adult spinal cord. Nat Commun. 2014;5:3338. https://doi.org/10.1038/ncomms4338.
Youmans JR. Youmans & Winn neurological surgery. Eighth edition. Philadelphia, PA: Elsevier; 2023.
Chang J, Qian Z, Wang B, Cao J, Zhang S, Jiang F, et al. Transplantation of A2 type astrocytes promotes neural repair and remyelination after spinal cord injury. Cell Commun Signal. 2023;21:37. https://doi.org/10.1186/s12964-022-01036-6.
Gao L, Peng Y, Xu W, He P, Li T, Lu X, et al. Progress in stem cell therapy for spinal cord injury. Stem Cells Int. 2020;2020:1–16. https://doi.org/10.1155/2020/2853650.
Karami Fath M, Babakhaniyan K, Anjomrooz M, Jalalifar M, Alizadeh SD, Pourghasem Z, et al. Recent advances in glioma cancer treatment: conventional and epigenetic realms. Vaccines. 2022;10:1448. https://doi.org/10.3390/vaccines10091448.
Chen X, Li H. Neuronal reprogramming in treating spinal cord injury. Neural Regen Res. 2022;17:1440–5. https://doi.org/10.4103/1673-5374.330590.
Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76. https://doi.org/10.1016/j.cell.2006.07.024.
Yang H, Liu CC, Wang CY, Zhang Q, An J, Zhang L, et al. Therapeutical strategies for spinal cord injury and a promising autologous astrocyte-based therapy using efficient reprogramming techniques. Mol Neurobiol. 2016;53:2826–42. https://doi.org/10.1007/s12035-015-9157-7.
Heinrich C, Blum R, Gascón S, Masserdotti G, Tripathi P, Sánchez R, et al. Directing astroglia from the cerebral cortex into subtype specific functional neurons. PLoS Biol. 2010;8:e1000373. https://doi.org/10.1371/journal.pbio.1000373.
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71. https://doi.org/10.1136/bmj.n71.
Brown JP, Couillard-Despres S, Cooper-Kuhn CM, Winkler J, Aigner L, Kuhn HG. Transient expression of doublecortin during adult neurogenesis. J Comp Neurol. 2003;467:1–10. https://doi.org/10.1002/cne.10874.
Gleeson JG, Lin PT, Flanagan LA, Walsh CA. Doublecortin is a microtubule-associated protein and is expressed widely by migrating neurons. Neuron. 1999;23:257–71. https://doi.org/10.1016/s0896-6273(00)80778-3.
Zarei-Kheirabadi M, Hesaraki M, Kiani S, Baharvand H. In vivo conversion of rat astrocytes into neuronal cells through neural stem cells in injured spinal cord with a single zinc-finger transcription factor. Stem Cell Res Ther. 2019;10:380. https://doi.org/10.1186/s13287-019-1448-x.
Tan Z, Qin S, Liu H, Huang X, Pu Y, He C, et al. Small molecules reprogram reactive astrocytes into neuronal cells in the injured adult spinal cord. J Adv Res. 2023:S2090123223001765. https://doi.org/10.1016/j.jare.2023.06.013.
Yang R-Y, Chai R, Pan J-Y, Bao J-Y, Xia P-H, Wang Y-K, et al. Knockdown of polypyrimidine tract binding protein facilitates motor function recovery after spinal cord injury. Neural Regen Res. 2023;18:396. https://doi.org/10.4103/1673-5374.346463.
Scheff SW, Saucier DA, Cain ME. A statistical method for analyzing rating scale data: the BBB locomotor score. J Neurotrauma. 2002;19:1251–60. https://doi.org/10.1089/08977150260338038.
Basso DM, Fisher LC, Anderson AJ, Jakeman LB, McTigue DM, Popovich PG. Basso mouse scale for locomotion detects differences in recovery after spinal cord injury in five common mouse strains. J Neurotrauma. 2006;23:635–59. https://doi.org/10.1089/neu.2006.23.635.
Hassannejad Z, Sharif-Alhoseini M, Shakouri-Motlagh A, Vahedi F, Zadegan SA, Mokhatab M, et al. Potential variables affecting the quality of animal studies regarding pathophysiology of traumatic spinal cord injuries. Spinal Cord. 2016;54:579–83. https://doi.org/10.1038/sc.2015.215.
Wang LL, Su Z, Tai W, Zou Y, Xu XM, Zhang CL. The p53 pathway controls SOX2-mediated reprogramming in the adult mouse spinal cord. Cell Rep. 2016;17:891–903. https://doi.org/10.1016/j.celrep.2016.09.038.
Puls B, Ding Y, Zhang F, Pan M, Lei Z, Pei Z, et al. Regeneration of functional neurons after spinal cord injury via in situ NeuroD1-mediated astrocyte-to-neuron conversion. Front Cell Dev Biol. 2020;8:591883. https://doi.org/10.3389/fcell.2020.591883.
Tan Z, Qin S, Yuan Y, Hu X, Huang X, Liu H, et al. NOTCH1 signaling regulates the latent neurogenic program in adult reactive astrocytes after spinal cord injury. Theranostics. 2022;12:4548–63. https://doi.org/10.7150/thno.71378.
Chen W, Zhang B, Xu S, Lin R, Wang W. Lentivirus carrying the NeuroD1 gene promotes the conversion from glial cells into neurons in a spinal cord injury model. Brain Res Bull. 2017;135:143–8. https://doi.org/10.1016/j.brainresbull.2017.10.001.
Kim J, Son Y, Hwang K, Park H, Kim Y, Kim M, et al. Synergistic enhancement of adeno‐associated virus‐mediated in vivo direct neuronal reprogramming by spatially aligned fibrous matrices in spinal cord injury models. Adv Therapeutics. 2023;6:2300040. https://doi.org/10.1002/adtp.202300040.
Feng GD, He BR, Lu F, Liu LH, Zhang L, Chen B, et al. Fibroblast growth factor 4 is required but not sufficient for the astrocyte dedifferentiation. Mol Neurobiol. 2014;50:997–1012. https://doi.org/10.1007/s12035-014-8649-1.
Shen K, Wu D, Sun B, Zhu Y, Wang H, Zou W, et al. Ginsenoside Rg1 promotes astrocyte‐to‐neuron transdifferentiation in rat and its possible mechanism. CNS Neurosci Ther. 2023;29:256–69. https://doi.org/10.1111/cns.14000.
All AH, Al-Nashash H. Comparative analysis of functional assessment for contusion and transection models of spinal cord injury. Spinal Cord. 2021;59:1206–9. https://doi.org/10.1038/s41393-021-00698-2.
Guo Z, Zhang L, Wu Z, Chen Y, Wang F, Chen G. In vivo direct reprogramming of reactive glial cells into functional neurons after brain injury and in an Alzheimer’s disease model. Cell Stem Cell. 2014;14:188–202. https://doi.org/10.1016/j.stem.2013.12.001.
Roybon L, Mastracci TL, Ribeiro D, Sussel L, Brundin P, Li J-Y. GABAergic differentiation induced by Mash1 is compromised by the bHLH proteins Neurogenin2, NeuroD1, and NeuroD2. Cereb Cortex. 2010;20:1234–44. https://doi.org/10.1093/cercor/bhp187.
Li T, Zhao X, Duan J, Cui S, Zhu K, Wan Y, et al. Targeted inhibition of STAT3 in neural stem cells promotes neuronal differentiation and functional recovery in rats with spinal cord injury. Exp Ther Med. 2021;22:711. https://doi.org/10.3892/etm.2021.10143.
Xu L, Tang Y-Y, Ben X-L, Cheng M-H, Guo W-X, Liu Y, et al. Ginsenoside Rg1-induced activation of astrocytes promotes functional recovery via the PI3K/Akt signaling pathway following spinal cord injury. Life Sci. 2020;252:117642. https://doi.org/10.1016/j.lfs.2020.117642.
Hu J, Qian H, Xue Y, Fu X-D. PTB/nPTB: master regulators of neuronal fate in mammals. Biophys Rep. 2018;4:204–14. https://doi.org/10.1007/s41048-018-0066-y.
Qian H, Kang X, Hu J, Zhang D, Liang Z, Meng F, et al. Reversing a model of Parkinson’s disease with in situ converted nigral neurons. Nature. 2020;582:550–6. https://doi.org/10.1038/s41586-020-2388-4.
Huangfu D, Maehr R, Guo W, Eijkelenboom A, Snitow M, Chen AE, et al. Induction of pluripotent stem cells by defined factors is greatly improved by small-molecule compounds. Nat Biotechnol. 2008;26:795–7. https://doi.org/10.1038/nbt1418.
Feng B, Ng J-H, Heng J-CD, Ng H-H. Molecules that promote or enhance reprogramming of somatic cells to induced pluripotent stem cells. Cell Stem Cell. 2009;4:301–12. https://doi.org/10.1016/j.stem.2009.03.005.
Yoon Y-E, Im BG, Kim J, Jang J-H. Multifunctional Self-Adhesive Fibrous Layered Matrix (FiLM) for tissue glues and therapeutic carriers. Biomacromolecules. 2017;18:127–40. https://doi.org/10.1021/acs.biomac.6b01413.
Acknowledgements
This work was Acknowledged and funded by the Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences [grant number is 99-2-93-49972].
Author information
Authors and Affiliations
Contributions
VRM conceived the presented idea and supervised the project. Z.G. revised the manuscript and communicated with team members and the corresponding author. SDA was responsible for writing the protocol and report, screening potentially eligible studies, extracting and analyzing data, interpreting results, assessing the risk of bias of included studies, creating tables and figures, discussing the results, and manuscript drafting. HM, GR, KM, MRJ and SS contributed to screening potentially eligible studies and extracting data. JH and SK were responsible for revising the manuscript and providing critical feedback. MSN analyzed and interpreted the data and results. ZE and RM conducted the database searches.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Ethical approval
The Ethics Committee of Sina Trauma and Surgery Research Center, Tehran University of Medical Sciences, approved the study, and the reference number is IR.TUMS.SINAHOSPITAL.REC.1399.114.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Alizadeh, S.D., Jalalifar, MR., Ghodsi, Z. et al. Reprogramming of astrocytes to neuronal-like cells in spinal cord injury: a systematic review. Spinal Cord 62, 133–142 (2024). https://doi.org/10.1038/s41393-024-00969-8
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41393-024-00969-8